Araştırma Makalesi
BibTex RIS Kaynak Göster

Bir Eğitim ve Araştırma Hastanesine Başvuran Kadınlarda Vajinit Prevalansı

Yıl 2026, Cilt: 11 Sayı: 1, 38 - 43, 14.03.2026
https://doi.org/10.58854/jicm.1878325
https://izlik.org/JA37FT68EM

Öz

Giriş ve Amaç: Vajinit, yaygın görülen bir jinekolojik durumdur ve asemptomatik olguların yüksek oranı, kendi kendine tanı koyma ve tedavi hataları gibi faktörler nedeniyle gerçek prevalansı değişkenlik göstermektedir. Bu çalışma, bir Eğitim ve Araştırma Hastanesine vajinit şikâyetiyle başvuran 18 yaş ve üzeri kadın hastalarda vajinit prevalansını retrospektif olarak değerlendirmeyi amaçlayan tanımlayıcı, kesitsel bir çalışma olarak tasarlanmıştır.
Yöntem: Hastalara ait demografik özellikler ile başvuru zamanı (gün, ay ve saat) ve yıllara göre hasta sayıları, bilgisayar tabanlı hasta kayıt sistemi kullanılarak retrospektif olarak taranmıştır.
Bulgular: Hastaların yaş ortalamasının 34,64±8,86 olduğu saptanmıştır. Başvuru yılları incelendiğinde hastaların %35,5’inin 2019 yılında, %18,8’inin 2020 yılında, %21’inin 2021 yılında ve %24,6’sının 2022 yılında değerlendirildiği belirlenmiştir. Hastaların %4,9’una smear testi önerilmiştir ve bu grubun yaş ortalamasının 39,88±7,14 olduğu görülmüştür. HPV testi ise hastaların %0,8’inden istenmiş olup bu hastaların yaş ortalamasının 40,27±6,45 yıl olduğu bulunmuştur.
Sonuç: Çalışmada, 18–49 yaş aralığında vajinit olgularının sık görülmesinin literatürle uyumlu olduğu saptanmıştır. Vajinal enfeksiyonların prevalansı ve nedenleri çok yönlüdür. Kadınlarda sık görülen önemli bir halk sağlığı sorunu olması ve tedavi edilmediğinde kronikleşme, infertilite ve kanser gibi ciddi sonuçlara yol açabilmesi nedeniyle, vajinit prevalansını değerlendiren çalışmaların literatürde artırılmasına ihtiyaç vardır.

Kaynakça

  • Holdcroft AM, Ireland DJ, Payne MS. The vaginal microbiome in health and disease: what role do common intimate hygiene practices play? Microorganisms. 2023;11(2):298.
  • Chang AW. Vaginitis. In: Chang AW, editor. Common cases in women’s primary care clinics. Cham: Springer International Publishing; 2024. p. 61–70.
  • Huang SH, Hsu HC, Lee TF, Fan HM, Tseng CW, Chen IH, et al. Prevalence, associated factors, and appropriateness of empirical treatment of trichomoniasis, bacterial vaginosis, and vulvovaginal candidiasis among women with vaginitis. Microbiol Spectr. 2023;11(3):e00161-23.
  • Zhou YX, Wang L, Wang TT, Qu XL, Zhang XQ. Analysis of HPV prevalence among individuals with reproductive tract infections in a Chinese population. Medicine (Baltimore). 2023;102(41):e34989.
  • Bignoumba M, Mbombe Moghoa KH, Muandze-Nzambe JU, Kassa Kassa RF, Mouanga Ndzime Y, Gafou A, et al. Vaginal infections’ etiologies in south-eastern Gabon: an overview. Int J Womens Health. 2022;14:505 515.
  • Pan Z, Wu Y, Li Y, Hu X, Zhao Y, Liu Y. Retrospective study of pathogens involved in vaginitis among Chinese women. BMC Womens Health. 2023;23(1):364.
  • Mujuzi H, Siya A, Wambi R. Infectious vaginitis among women seeking reproductive health services at a sexual and reproductive health facility in Kampala, Uganda. BMC Womens Health. 2023;23(1):677.
  • Czeisler MÉ. Delay or avoidance of medical care because of COVID-19–related concerns— United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1250–1257.
  • Santella B, Schettino MT, Franci G, De Franciscis P, Colacurci N, Schiattarella A, et al. Microbiota and HPV: the role of viral infection on vaginal microbiota. J Med Virol. 2022;94(9):4478–4484.
  • Holm JB, France MT, Gajer P, Ma B, Brotman RM, Shardell M, et al. Integrating compositional and functional content to describe vaginal microbiomes in health and disease. Microbiome. 2023;11(1):259.
  • Marnach ML, Wygant JN, Casey PM. Evaluation and management of vaginitis. Mayo Clin Proc. 2022;97(2):347–358.
  • Pereira HF, Nunes GP, Pereira HV, Silva KD, Olenchi MM, Silva TC, et al. Human papillomavirus prevalence and frequency of sexually transmitted diseases in incarcerated women by self-sampling approach. Rev Assoc Med Bras (1992). 2023;69(8):e20230204.

Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital

Yıl 2026, Cilt: 11 Sayı: 1, 38 - 43, 14.03.2026
https://doi.org/10.58854/jicm.1878325
https://izlik.org/JA37FT68EM

Öz

Introduction and Objective: Vaginitis is a common gynecological condition, and its true prevalence varies due to factors such as a high proportion of asymptomatic cases, self-diagnosis, and treatment errors. This study was designed as a descriptive, cross-sectional study aimed at retrospectively evaluating the prevalence of vaginitis among female patients aged 18 years and older who presented to a Training and Research Hospital with complaints of vaginitis.
Methods: Data on patients’ demographic characteristics, time of presentation (day, month, and hour), and the number of patients by year were retrospectively reviewed using a computer-based patient registration system.
Results: The average age of the patients was found to be 34.64±8.86. When examining the years of examination, it was found that 35.5% of the patients were examined in 2019, 18.8% in 2020, 21% in 2021, and 24.6% in 2022. It was observed that a smear test was recommended for 4.9% of the patients, and their average age was 39.88±7.14. It was found that an HPV test was requested for 0.8% of the patients, with an average age of 40.27±6.45 years.
Conclusion: The study determined that the frequent cases of vaginitis in the 18-49 age range were consistent with the literature. The prevalence and causes of vaginal infections are multifaceted. Since it is a significant public health issue commonly seen in women and, if left untreated, can lead to chronic conditions, infertility, and cancer, there is a need to increase studies in the literature evaluating the prevalence of vaginitis.

Etik Beyan

Before starting the research, the necessary permissions were obtained from the Ethics Committee of the Institute of Health Sciences at Kırklareli University (Protocol No: PR0448R01, Decision No: 2, Decision Date: 20.03.2023) and from the Kırklareli Provincial Health Directorate (Decision No: 16, Decision Date: 01.06.2023).

Destekleyen Kurum

Kırklareli University

Teşekkür

We thank the Kırklareli Provincial Health Directorate for their support in conducting the research.

Kaynakça

  • Holdcroft AM, Ireland DJ, Payne MS. The vaginal microbiome in health and disease: what role do common intimate hygiene practices play? Microorganisms. 2023;11(2):298.
  • Chang AW. Vaginitis. In: Chang AW, editor. Common cases in women’s primary care clinics. Cham: Springer International Publishing; 2024. p. 61–70.
  • Huang SH, Hsu HC, Lee TF, Fan HM, Tseng CW, Chen IH, et al. Prevalence, associated factors, and appropriateness of empirical treatment of trichomoniasis, bacterial vaginosis, and vulvovaginal candidiasis among women with vaginitis. Microbiol Spectr. 2023;11(3):e00161-23.
  • Zhou YX, Wang L, Wang TT, Qu XL, Zhang XQ. Analysis of HPV prevalence among individuals with reproductive tract infections in a Chinese population. Medicine (Baltimore). 2023;102(41):e34989.
  • Bignoumba M, Mbombe Moghoa KH, Muandze-Nzambe JU, Kassa Kassa RF, Mouanga Ndzime Y, Gafou A, et al. Vaginal infections’ etiologies in south-eastern Gabon: an overview. Int J Womens Health. 2022;14:505 515.
  • Pan Z, Wu Y, Li Y, Hu X, Zhao Y, Liu Y. Retrospective study of pathogens involved in vaginitis among Chinese women. BMC Womens Health. 2023;23(1):364.
  • Mujuzi H, Siya A, Wambi R. Infectious vaginitis among women seeking reproductive health services at a sexual and reproductive health facility in Kampala, Uganda. BMC Womens Health. 2023;23(1):677.
  • Czeisler MÉ. Delay or avoidance of medical care because of COVID-19–related concerns— United States, June 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1250–1257.
  • Santella B, Schettino MT, Franci G, De Franciscis P, Colacurci N, Schiattarella A, et al. Microbiota and HPV: the role of viral infection on vaginal microbiota. J Med Virol. 2022;94(9):4478–4484.
  • Holm JB, France MT, Gajer P, Ma B, Brotman RM, Shardell M, et al. Integrating compositional and functional content to describe vaginal microbiomes in health and disease. Microbiome. 2023;11(1):259.
  • Marnach ML, Wygant JN, Casey PM. Evaluation and management of vaginitis. Mayo Clin Proc. 2022;97(2):347–358.
  • Pereira HF, Nunes GP, Pereira HV, Silva KD, Olenchi MM, Silva TC, et al. Human papillomavirus prevalence and frequency of sexually transmitted diseases in incarcerated women by self-sampling approach. Rev Assoc Med Bras (1992). 2023;69(8):e20230204.
Toplam 12 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Tıbbi Enfeksiyon Ajanları
Bölüm Araştırma Makalesi
Yazarlar

Hilal Tabaksoy 0000-0003-1896-5612

Özgenur Hacıoğlu 0000-0002-8223-4737

Gönderilme Tarihi 30 Ocak 2026
Kabul Tarihi 5 Mart 2026
Yayımlanma Tarihi 14 Mart 2026
DOI https://doi.org/10.58854/jicm.1878325
IZ https://izlik.org/JA37FT68EM
Yayımlandığı Sayı Yıl 2026 Cilt: 11 Sayı: 1

Kaynak Göster

APA Tabaksoy, H., & Hacıoğlu, Ö. (2026). Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital. Journal of Immunology and Clinical Microbiology, 11(1), 38-43. https://doi.org/10.58854/jicm.1878325
AMA 1.Tabaksoy H, Hacıoğlu Ö. Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital. J Immunol Clin Microbiol. 2026;11(1):38-43. doi:10.58854/jicm.1878325
Chicago Tabaksoy, Hilal, ve Özgenur Hacıoğlu. 2026. “Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital”. Journal of Immunology and Clinical Microbiology 11 (1): 38-43. https://doi.org/10.58854/jicm.1878325.
EndNote Tabaksoy H, Hacıoğlu Ö (01 Mart 2026) Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital. Journal of Immunology and Clinical Microbiology 11 1 38–43.
IEEE [1]H. Tabaksoy ve Ö. Hacıoğlu, “Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital”, J Immunol Clin Microbiol, c. 11, sy 1, ss. 38–43, Mar. 2026, doi: 10.58854/jicm.1878325.
ISNAD Tabaksoy, Hilal - Hacıoğlu, Özgenur. “Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital”. Journal of Immunology and Clinical Microbiology 11/1 (01 Mart 2026): 38-43. https://doi.org/10.58854/jicm.1878325.
JAMA 1.Tabaksoy H, Hacıoğlu Ö. Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital. J Immunol Clin Microbiol. 2026;11:38–43.
MLA Tabaksoy, Hilal, ve Özgenur Hacıoğlu. “Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital”. Journal of Immunology and Clinical Microbiology, c. 11, sy 1, Mart 2026, ss. 38-43, doi:10.58854/jicm.1878325.
Vancouver 1.Hilal Tabaksoy, Özgenur Hacıoğlu. Prevalence of Vaginitis in Women Admitted to a Training and Research Hospital. J Immunol Clin Microbiol. 01 Mart 2026;11(1):38-43. doi:10.58854/jicm.1878325

88x31.png 

Creative Commons Attribution Non-Commercial License: The articles in the Journal of Immunology and Clinical Microbiology are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

JICM bir QMEL® Tıp & Yayınevi ürünüdür.